COVID-19 Vaccines International Pregnancy Exposure Registry
Recruiting
Observational Study
Covid19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Observational
- Participants needed
- 6,000 (estimated)
- Sponsor
- Pregistry · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER) is to evaluate obstetric, neonatal, and infant outcomes among women vaccinated during pregnancy with a COVID-19 vaccine.
Specifically, the C-VIPER will estimate the risk of obstetric outcomes (spontaneous abortion, antenatal bleeding, gestational diabetes, gestational hypertension, intrauterine growth restr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
Vaccinated population:
* Pregnant at time of enrollment
* Age ≥18 years at time of enrollment
* Signed the informed consent form and submitted the baseline module "COVID-19 Vaccination During This Pregnancy"
* Received at least one dose of a COVID-19 vaccine during pregnancy or…
Contacts